Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 23494 [2016-09271]

Download as PDF 23494 Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices jstallworth on DSK7TPTVN1PROD with NOTICES March 28, 2003. The fee increase will compensate GSA for the increased operational costs of maintaining the .gov top-level domain (TLD). The fee will be the same for new registrations and for annual renewals. This document establishes the fee for all entities that use the .gov TLD at $400 per annum, effective January 1, 2017. DATES: Effective: May 23, 2016. FOR FURTHER INFORMATION CONTACT: Contact Mr. Lee Ellis, Office of Government-wide Policy, at 202–501– 0282, or via email to lee.ellis@gsa.gov for clarification of content. For information pertaining to status or publication schedules, contact the Regulatory Secretariat Division at 202– 501–4755. Please cite Notice ME–2016– 01. SUPPLEMENTARY INFORMATION: Background The .gov domain was first established in 1985 under the Internet Engineering Task Force of the Internet Society, RFC 920, 1480, 1591, 1811, and 2146 as a generic top-level domain (TLD) for government entities in the United States. In 2003, GSA published the Federal Management Regulation final rule, Internet GOV Domain (41 CFR part 102–173), at 68 FR 15089 (March 28, 2003), which codified existing guidance and best practice methods for domain management, then stratified across governmental and non-governmental bodies, and expanded the .gov domain to permit inclusion of state, local, and tribal governments (SLTTs). GSA is designated as the TLD owner and Domain Policy Authority for governmental entities in the United States, including Federal, state, local and tribal governments. OGP oversees the enabling rule (41 CFR part 102–173, Internet GOV Domain—hereafter ‘‘Final Rule’’) and administers the .gov domain registration and renewal process in accordance with the original rule and the .gov Domain Registration and Management Guidance. The rule and the guidance govern registrations and renewals for second-level domains under the top level .gov domain. When GSA published the Final Rule in 2003, it initiated the assessment of fees for the registration and annual renewal .gov domains by Federal Government agencies, the Legislative Branch, the Judicial Branch, and SLTTs. At the time, GSA stated in the Federal Register that the Final Rule ‘‘merely establishes a ceiling for the charges that GSA may assess in the future if circumstances require it. These charges, if established, will be based on the costs of operations and market rates.’’ VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 Since publication of the Final Rule, all bodies seeking to register and use a .gov domain are assessed a $125 per annum fee for registration and for annual renewals. The fee has remained unchanged since 2003, even as new laws, enhanced security protocols, protections and controls, and increased operational costs have substantially raised the overall cost for GSA to manage the .gov domain. OGP solicited advice and feedback from stakeholders representing all levels of government, internationally, as well as the private sector to better inform decision-making about whether a per annum fee increase should occur. The research details also yielded insight as to the amount the increase would be considered reasonable. 41 CFR 102–173.45 sets the fee for new .gov domain registrations at no more than $1,000 per year, and the charge for annual .gov domain renewals at no more than $500 per year. The current fee of $125 per annum has been in effect since publication of the Final Rule. To compensate for increased operational costs and security requirements of maintaining the .gov domain, GSA will raise the fee for both new registrations and annual renewals to $400 per annum. This fee will be the same for all entities who apply to initially register, or renew, an existing registration of a .gov second-level domain name and are approved, per 41 CFR 102–173. Dated: April 14, 2016. Troy Cribb, Associate Administrator, Office of Government-wide Policy, General Services Administration. [FR Doc. 2016–09294 Filed 4–20–16; 8:45 am] BILLING CODE 6820–14–P Time and Date: 10:00 a.m.–12:00 p.m., EDT, May 12, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to FOA PS16–002, Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment’’, FOA PS16–002. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, MPH, DLP, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–09271 Filed 4–20–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) RFA 16–010, Occupational Safety and Health Research, NIOSH National Mesothelioma Virtual Bank for Translational Research Review. Time and Date: 1:00 p.m.–5:00 p.m., EDT, May 19, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) PS16–002, Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Page 23494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09271]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
PS16-002, Cohort Study to Assess Population Impact of Current and 
Evolving Chronic Viral Hepatitis Treatment.

    Time and Date: 10:00 a.m.-12:00 p.m., EDT, May 12, 2016 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to FOA PS16-002, Cohort Study to Assess Population Impact of Current 
and Evolving Chronic Viral Hepatitis Treatment'', FOA PS16-002.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker, MPH, DLP,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-09271 Filed 4-20-16; 8:45 am]
 BILLING CODE 4163-18-P